Webinar details
- January 29, 2026
The production of cell-based vaccines demands robust, contamination-free upstream processes to ensure product safety, regulatory compliance and manufacturing efficiency. However, identifying high-quality, animal-free raw materials that consistently perform across established cell systems remains a key challenge for vaccine manufacturers.
In this webinar, we will present validated solutions using recombinant insulin and recombinant trypsin to support safe, efficient and animal-free vaccine production. Learn how recombinant insulin enhances cell culture performance and increases viral yield in widely used systems such as Vero and HEK293 cells. We will also explore how high-purity recombinant trypsin improves cell dissociation, virus infectivity and overall product quality, while eliminating the contamination risks associated with animal-derived reagents.
This webinar is designed for scientists, process developers, cell line development specialists, vaccine manufacturers, quality assurance professionals, procurement teams, engineers and product managers working in vaccine development and biopharmaceutical manufacturing.
Watch the webinar
Speakers
Sara Bursomanno, PhD, Senior Global Product Manager
Sara Bursomanno is a seasoned expert in Cancer Biology with over a decade of experience in academic research. Having transitioned to the biopharmaceutical industry over six years ago, Sara has excelled as a Product Manager, focusing on the upstream manufacturing of biological drugs.
Her specialized knowledge in cell culture and protein production allows her to effectively bridge the gap between scientific research and practical industry applications.
Chantale Julien, Global Product Manager
With over 20 years of experience in the pharmaceutical industry, Chantale is currently a Global Product Manager at Novo Nordisk Pharmatech A/S, where she manages several product portfolios.
Her role encompasses providing technical and scientific support, strategic market positioning and adherence to GXP requirements.
Throughout her career, she has held positions at the Canadian Food Inspection Agency, Novonesis (previously Chr. Hansen A/S) and Cook Medical, in various management roles that emphasize compliance, life-cycle product management and API distribution.
Mrs. Julien earned her Master’s degree in Animal Sciences from Université Laval in Québec, Canada.
